With an increasing prevalence during the past decades, atopic dermatitis has become a
global health issue. A literature search following a targeted approach was undertaken to …

Glucocorticoids regulate fundamental processes of the human body and control cellular
functions such as cell metabolism, growth, differentiation, and apoptosis. Moreover …

The evidence‐and consensus‐based guideline on atopic eczema was developed in
accordance with the EuroGuiDerm Guideline and Consensus Statement Development …

Atopic dermatitis (AD) is a highly pruritic, chronic inflammatory skin disease. The diagnosis
is made using evaluated clinical criteria. Disease activity and burden are best measured …

This guideline was developed as a joint interdisciplinary European project, including
physicians from all relevant disciplines as well as patients. It is a consensus‐based …

Background There are gaps in our knowledge of the prevalence of adult atopic dermatitis
(AD). Objective To estimate the prevalence of AD in adults and by disease severity. Methods …

This guideline was developed as a joint interdisciplinary European project, including
physicians from all relevant disciplines as well as patients. It is a consensus‐based …

Background Dupilumab, a human monoclonal antibody against interleukin-4 receptor alpha,
inhibits signaling of interleukin-4 and interleukin-13, type 2 cytokines that may be important …

Background Atopic dermatitis is a chronic inflammatory skin disease that may require
systemic therapy. Ciclosporin A (CsA) is a widely used, potent immunosuppressant but it is …

Background Interleukin-31 may play a role in the pathobiologic mechanism of atopic
dermatitis and pruritus. We wanted to assess the efficacy and safety of nemolizumab …